Panton-Valentine Leucocidin-related disease in England and Wales

Clinical Microbiology and Infection

Volumn 16, Issue 1, 2010, Pages 86-88

  Ellington, M J ^a   Ganner, M ^a   Smith, I M ^a   Perry, C ^a   Cookson, B D ^b   Kearns, A M ^a  

^a Staphylococcus Reference Unit (SRU)   (United Kingdom)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

MRSA; MSSA; PVL

Indexed keywords

CIPROFLOXACIN; OXACILLIN; PANTON VALENTINE LEUKOCIDIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEREMIA; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CLINICAL PRACTICE; DRUG EFFICACY; EVIDENCE BASED PRACTICE; FULMINATING PURPURA; HUMAN; INFECTION CONTROL; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN SENSITIVE STAPHYLOCOCCUS AUREUS; MICROBIOLOGICAL EXAMINATION; NECROTIZING FASCIITIS; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; SEPTIC SHOCK; SKIN INFECTION; SOFT TISSUE INFECTION; STAPHYLOCOCCUS AUREUS; UNITED KINGDOM;

METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS AUREUS;

EID: 71849083236     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2009.02887.x     Document Type: Article

References (13)

1. Zetola N, Francis JS, Nuermberger EL, Bishai WR. Community-acquired meticillin-resistant Staphylococcus aureus: an emerging threat. Lancet Infect Dis 2005, 5:275-286.
2. Otter JA, French GL. The emergence of community-associated methicillin-resistant Staphylococcus aureus at a London teaching hospital, 2000-2006. Clin Microbiol Infect 2008, 14:670-676.
3. Lina G, Piemont Y, Godail-Gamot F. Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis 1999, 29:1128-1132.
4. Miller LG, Perdreau-Remington F, Rieg G. Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles. N Engl J Med 2005, 352:1445-1453.
5. Kravitz GR, Dries DJ, Peterson ML, Schlievert PM. Purpura fulminans due to Staphylococcus aureus. Clin Infect Dis 2005, 40:941-947.
6. Gillet Y, Issartel B, Vanhems P. Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. Lancet 2002, 359:753-759.
7. Robinson DA, Kearns AM, Holmes A. Re-emergence of early pandemic Staphylococcus aureus as a community-acquired meticillin-resistant clone. Lancet 2005, 365:1256-1258.
8. Diederen BM, Kluytmans JA. The emergence of infections with community-associated methicillin resistant Staphylococcus aureus. J Infect 2006, 52:157-168.
9. Hospital-associated transmission of Panton-Valentine Leukocidin (PVL) positive community-associated MRSA in the West Midlands 2006. http://www.camr.org.uk/cdr/archives/archive06/News/news5006.htm, CDR weekly 14 December 2006. Available at: Last accessed 24 February 2009
10. Morgan M. Staphylococcus aureus, Panton-Valentine leukocidin, and necrotising pneumonia. BMJ 2005, 331:793-794.
11. Davis SL, Perri MB, Donabedian SM. Epidemiology and outcomes of community-associated methicillin-resistant Staphylococcus aureus infection. J Clin Microbiol 2007, 45:1705-1711.
12. Kourbatova EV, Halvosa JS, King MD, Ray SM, White N, Blumberg HM. Emergence of community-associated methicillin-resistant Staphylococcus aureus USA 300 clone as a cause of health care-associated infections among patients with prosthetic joint infections. Am J Infect Control 2005, 33:385-391.
13. Seybold U, Kourbatova EV, Johnson JG. Emergence of community-associated methicillin-resistant Staphylococcus aureus USA300 genotype as a major cause of health care-associated blood stream infections. Clin Infect Dis 2006, 42:647-656.